Effects of Sophora alopecuroides on the opium withdrawal symptoms

Phase 3

Recruiting

• Conditions: Opium addiction.; Opioid dependence with withdrawal; F11.23

• Registration Number: IRCT20090804002288N15
• Lead Sponsor: Iranian academic center for education culture and research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 May 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 100

Inclusion Criteria

Iranian male outpatients who according to the DSM-V criteria are dependent on opium for at least 1 year
Patients aged 18 to 70 years
Patients whose opium dose has been constant for at least one month before study
Patients residing in addiction treatment camp
Patients who have not used opium for at least 5 hours before arrival in camp

Exclusion Criteria

Individuals who besides opium abuse other substances except for tobacco
Patients who have other psychiatric diseases
Individuals who have other important diseases like cardiac, renal and hepatic disease
Individuals who have organic brain disease
Individuals who have mental retardation

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Score of clinical opiate withdrawal scale. Timepoint: Before intervention and 3 and 8 days after intervention. Method of measurement: Clinical Opiate Withdrawal Scale.;Patient global impression regarding efficacy of treatment. Timepoint: Eight days after intervention. Method of measurement: Visual analog scale (ten centimeter ruler).